On the basis of our findings and conclusions, we hypothesize that inhibiting the FGF7-FGFR2 pathway to reduce ACE2 expression could help prevent viral infection thereby ameliorate COVID-19. This evidence concerns the gene FGF7 and viral infectious disease.